Lu Zhang Selected Research

ErbB Receptors (EGF Receptor)

1/2023	EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study.
3/2022	Photothermolysis Mediated by Gold Nanorods Conjugated with Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Induces Apoptosis via the Mitochondrial Apoptosis Pathway in Laryngeal Squamous Cell Cancer.
1/2022	Optimization of endothelial growth factor receptor monoclonal antibody-gold nanorods photothermal therapy for laryngeal squamous cell carcinoma.
1/2022	MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
11/2021	An intelligent hypoxia-relieving chitosan-based nanoplatform for enhanced targeted chemo-sonodynamic combination therapy on lung cancer.
5/2021	A non-small cell lung cancer (NSCLC) patient with leptomeningeal metastasis harboring rare epidermal growth factor receptor (EGFR) mutations G719S and L861Q benefited from doubling dosage of osimertinib: a case report.
1/2021	The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment.
1/2021	Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer.
10/2018	A combined subtype of small cell lung cancer and adenocarcinoma with epidermal growth factor receptor (EGFR) mutation responds to EGFR tyrosine kinase inhibitors.
5/2018	Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I-III breast cancer: ER+/PR+, HER2- vs. triple-negative.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lu Zhang Research Topics

Disease

499	Neoplasms (Cancer) 05/2024 - 12/2003
133	Inflammation (Inflammations) 06/2024 - 07/2010
106	Infections 04/2024 - 04/2007
81	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2012
55	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2011
50	COVID-19 03/2024 - 01/2020
49	Carcinogenesis 01/2024 - 04/2010
47	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2012
46	Fibrosis (Cirrhosis) 05/2024 - 09/2007
38	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2014
37	Chronic Hepatitis B 03/2024 - 09/2007
35	Nasopharyngeal Carcinoma 05/2024 - 10/2012
35	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 02/2013
35	Hypoxia (Hypoxemia) 05/2024 - 09/2004
34	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2008
33	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 04/2009
32	Obesity 12/2024 - 11/2012
28	Lung Neoplasms (Lung Cancer) 04/2024 - 12/2003
27	Wounds and Injuries (Trauma) 05/2024 - 01/2011
27	Body Weight (Weight, Body) 01/2024 - 01/2012
25	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2013
25	Hepatitis B 12/2023 - 04/2003
24	Insulin Resistance 02/2024 - 04/2009
24	Pain (Aches) 05/2023 - 01/2013
24	Type 2 Diabetes Mellitus (MODY) 02/2023 - 03/2006
22	Heart Failure 11/2023 - 10/2012
22	Myocardial Infarction 09/2022 - 01/2011
22	Multiple Myeloma 04/2022 - 10/2007
21	Melanoma (Melanoma, Malignant) 01/2024 - 07/2010
20	Disease Progression 03/2024 - 05/2010
20	Hypertension (High Blood Pressure) 01/2024 - 12/2009
20	Rheumatoid Arthritis 01/2024 - 07/2011
19	Glioma (Gliomas) 04/2024 - 10/2016
19	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 10/2016
19	Atherosclerosis 03/2024 - 10/2008
18	Squamous Cell Carcinoma of Head and Neck 04/2024 - 10/2012
18	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 11/2013
17	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 05/2015
17	Adenocarcinoma of Lung 04/2024 - 05/2013
16	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2024 - 12/2015
16	Osteosarcoma (Osteogenic Sarcoma) 04/2024 - 05/2016
16	Carcinoma (Carcinomatosis) 11/2023 - 12/2003
15	Stroke (Strokes) 04/2024 - 06/2013
15	Pneumonia (Pneumonitis) 03/2024 - 12/2015
15	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 10/2008
14	Necrosis 04/2024 - 10/2007

Drug/Important Bio-Agent (IBA)

159	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2004
132	Biomarkers (Surrogate Marker)IBA 12/2024 - 12/2011
77	MicroRNAs (MicroRNA)IBA 04/2024 - 12/2012
65	CytokinesIBA 04/2024 - 01/2006
52	Messenger RNA (mRNA)IBA 03/2024 - 10/2005
51	RNA (Ribonucleic Acid)IBA 06/2024 - 10/2012
46	Therapeutic UsesIBA 05/2024 - 06/2009
46	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 04/2009
45	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 09/2007
38	Long Noncoding RNAIBA 04/2024 - 11/2016
35	Circular RNAIBA 04/2024 - 01/2016
34	Antiviral Agents (Antivirals)IBA 03/2024 - 10/2008
32	AntigensIBA 12/2023 - 06/2009
29	Small Interfering RNA (siRNA)IBA 05/2024 - 01/2010
29	Transcription Factors (Transcription Factor)IBA 10/2023 - 04/2006
28	AntibodiesIBA 01/2024 - 10/2007
28	Peptides (Polypeptides)IBA 11/2023 - 12/2009
27	LipidsIBA 05/2024 - 03/2006
25	Hepatitis B e AntigensIBA 12/2023 - 11/2015
24	InterferonsIBA 03/2024 - 09/2007
22	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 01/2013
22	Interleukin-6 (Interleukin 6)IBA 04/2024 - 02/2010
21	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2020
21	LigandsIBA 04/2024 - 02/2011
21	EnzymesIBA 03/2024 - 08/2010
21	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 09/2004
20	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2024 - 11/2015
20	VaccinesIBA 01/2024 - 06/2008
19	AntioxidantsIBA 05/2024 - 12/2013
19	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 06/2016
19	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2012
19	AcidsIBA 01/2024 - 06/2007
19	Oxygen (Dioxygen)IBA 10/2023 - 01/2016
18	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 10/2014
18	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2023 - 10/2007
16	CateninsIBA 01/2023 - 01/2018
15	Hormones (Hormone)IBA 04/2024 - 01/2013
15	HydrogelsIBA 04/2024 - 11/2014
15	Amino Acids FDA Link 01/2024 - 06/2011
15	Indicators and Reagents (Reagents)IBA 01/2024 - 08/2013
15	Phosphotransferases (Kinase)IBA 07/2023 - 08/2011
14	CollagenIBA 04/2024 - 01/2013
14	LipopolysaccharidesIBA 02/2024 - 06/2011
14	Tyrosine Kinase InhibitorsIBA 10/2023 - 09/2004
14	GoldIBA 10/2023 - 05/2003
14	Insulin (Novolin)FDA Link 01/2023 - 08/2006

Therapy/Procedure

306	Therapeutics 05/2024 - 01/2006
88	Drug Therapy (Chemotherapy) 05/2024 - 06/2008
50	Immunotherapy 05/2024 - 12/2006
41	Radiotherapy 03/2024 - 10/2012
21	Aftercare (After-Treatment) 11/2023 - 06/2007
20	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 11/2013
19	Chemoradiotherapy 01/2023 - 01/2013
14	Photochemotherapy (Photodynamic Therapy) 01/2023 - 01/2017